August 13, 2022
Loading...
You are here:  Home  >  Banking & Finance  >  Tri-County Public Companies  >  Earnings  >  Current Article

New drugs boost profits at Amgen as two executives leave company

IN THIS ARTICLE

Newer products drove strong increases in second quarter earnings for Amgen. The Thousand Oaks biotech giant also announced that two key executives are leaving the company and it has made steps toward continuing to fill its pipeline with new early stage investments. A $1.32 per share dividend is also slated for September after the company…

Subscribe

    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.